NeuroSense Moves Forward with Nasdaq Hearing as PrimeC Reaches Crucial Milestones #United_States #Cambridge #ALS #NeuroSense #PrimeC
@newsen.bsky.social
@newsen.bsky.socialNeuroSense Moves Forward with Nasdaq Hearing as PrimeC Reaches Crucial Milestones #United_States #Cambridge #ALS #NeuroSense #PrimeC
@newsen.bsky.socialNeuroSense Updates on Compliance Status with Nasdaq Listing Requirements #USA #Cambridge #biotechnology #NeuroSense #NRSN
@newsen.bsky.socialNeuroSense Therapeutics to Showcase Innovations at the 5th Annual ROTH Healthcare Opportunities Conference #United_States #New_York #ALS #NeuroSense #PrimeC
@newsen.bsky.socialNeuroSense's Strategies and Financial Results for the First Half of 2026 #United_States #Cambridge #ALS #NeuroSense #PrimeC
@newsen.bsky.socialNeuroSense's Participation at the 28th Annual H.C. Wainwright Global Investment Conference #United_States #New_York #Conference #ALS #NeuroSense